Skin toxicity after administration of low-dose cytarabine

Medical and Pediatric Oncology

Volumn 33, Issue 4, 1999, Pages 420-421

  Kantar, Mehmet ^a   Cetingül, Nazan ^a   Öniz, Haldun ^a   Aydinok, Yeşim ^a   Kavakli, Kaan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Childhood cancer; Cytarabine; Exanthemata; Skin; Toxicity

Indexed keywords

ALPHA INTERFERON; BECLOMETASONE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; FOLIC ACID; GLUCONATE CALCIUM; MITOXANTRONE; RECOMBINANT ERYTHROPOIETIN; TIOGUANINE;

CANCER CHEMOTHERAPY; CASE REPORT; CHILD; CLINICAL FEATURE; CONFERENCE PAPER; ERYTHEMA NODOSUM; FEMALE; HUMAN; LEUKEMIA; MALE; PRIORITY JOURNAL; SKIN TOXICITY; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CYTARABINE; ERYTHEMA NODOSUM; EXANTHEMA; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; SKIN DISEASES; URTICARIA;

EID: 0032835406     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199910)33:4<420::AID-MPO19>3.0.CO;2-B     Document Type: Conference Paper

References (5)

1. Chabner B. Cytidine anologues. In: Chabner BA, Longo DL, editors. Cancer chemotherapy and biotherapy. Philadelphia: Lippincott-Raven, Inc.; 1996. p 228-229.
2. Calabresi P, Chabner BA. Chemotherapy of neoplastic diseases. In: Hardmann JG, Limbird LE, editors. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw Hill, Inc.; 1996. p 1251-1253.
3. Haskell CM. Antineoplastic agents. In: Haskell CM, editor. Cancer treatment. Philadelphia: W.B. Saunders, Inc.; 1995. p 99-101.
4. Yokel BK, Hood AF. Mucocutaneous complications of antineo-plastic therapy. In: Fitzpatrick TB. editor. Dermatology in medicine. NewYork: McGraw Hill, Inc; 1993. p 1800.
5. Peters WG, Willemze R, Colly LP, Guiot HFL. Side effects of intermediate and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukemia and non-Hodgkin's lymphoma. Netherlands J Med 1987;30:64-74.